Skip to main content

Table 2 Labor characteristics of both groups in both groups

From: A pilot study to compare propranolol and misoprostol versus misoprostol and placebo for induction of labor in primigravidae; a randomized, single-blinded, placebo-controlled trial

 

Group I

Propranolol &misoprostol

N = 64

Group II

placebo &misoprostol

N = 64

P-value

Indication of induction

Post date (n %)

39

60.9%

44

68.8%

0.355 NS 1

ROM (n %)

18

28.1%

10

15.6%

0.08 NS 1

 

HTN (n %)

6

9.4%

9

14.1%

0.41*NS 1

 

GDM (n %)

1

1.6%

1

1.6%

1.0 NS 2

 

Mode of delivery

NVD (n %)

45

70.3%

39

60.9%

0.264 NS 2

CS (n %)

19

29.7%

25

39.1%

  

Duration of Latent phase (hours)

(45 cases in group I,

39 cases in group II)

Mean ± SD

7.9 ± 5.6

9.2 ± 6.03

0.017 S 3

 

Duration of Active

Phase (hours)

(45 cases in group I,

39 cases in group II)

Mean ± SD

3.9 ± 2.7

3.5 ± 2.9

0.425 NS 3

 

Induction-delivery interval (hours)

(45 cases in group I,

39 cases in group II)

Mean ± SD

11.8 ± 8.1

12.6 ± 8.9

0.027 S 3

 

Misoprostol dose (No. of doses) (45 cases in group I, 39 cases in group II)

1 dose (n %)

14

31.1%

14

35.9%

0.79 NS 2

 

2 dose (n %)

28

62.2%

22

56.4%

 

3 dose (n %)

2

4.4%

2

5.1%

 

4 dose (n %)

1

2.2%

1

2.6%

 

Oxytocin dose(units)

(45 cases in group I, 39 cases in group II)

0 unit (n %)

26

57.8%

22

56.4%

0.834 2 NS

 

5 units (n %)

14

31.1%

13

33.3%

 

10 units (n %)

4

8.9%

2

5.1%

 

15 units (n %)

1

2.2%

2

5.1%

 

Indication of CS

(19 cases in group I, 25 cases in group II)

Failed progress (n %)

7

36.8%

9

36%

0.713 NS 2

 

Fetal distress (n) %)

10

52.6%

15

60%

 

Failed induction (n %)

2

10.5%

1

4%

 
  1. aChi square test
  2. bFisher exact
  3. cMann Whitney test
  4. S significant, NS Non-significant, ROM Rupture of membranes, HTN Hypertension, GDM Gestational Diabetes Mellites, NVD Normal Vaginal Delivery, n number